After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Amylyx Pharmaceuticals Inc is $334.91M. A total of 0.77 million shares were traded on the day, compared to an average of 842.38K shares.
In the most recent transaction, FRATES JAMES M sold 10,896 shares of AMLX for 3.47 per share on Mar 31 ’25. After the transaction, the Chief Financial Officer now owns 290,988 company shares. In a previous transaction on Mar 31 ’25, Bedrosian Camille L sold 12,425 shares at 3.47 per share. AMLX shares that Chief Medical Officer owns now total 194,375.
Among the insiders who sold shares, Mazzariello Gina disposed of 9,192 shares on Mar 31 ’25 at a per-share price of $3.48. This resulted in the Chief Legal Officer holding 187,969 shares of AMLX after the transaction. In another insider transaction, Cohen Joshua B sold 21,490 shares at $3.47 per share on Mar 31 ’25. Company shares held by the Co-Chief Executive Officer now total 3,355,280.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, AMLX has a high of $7.27 and a low of $1.58.
As of this writing, AMLX has an earnings estimate of -$0.55 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$0.55 per share and a lower estimate of -$0.55.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AMLX’s latest balance sheet shows that the firm has $96.12M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $17.40M in liabilities at the time. Its Book Value Per Share was $2.40, while its Total Shareholder’s Equity was -$151.17M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMLX is Buy with a score of 3.86.
